12th Edition of International Conference on Neurology and Brain Disorders
October 20-22, 2025
Neurotoxicology
Neurotoxicology examines the harmful effects that toxic substances have on the nervous system, particularly how chemicals disrupt the brain's structure and function. Neurotoxins, which can be found in environmental pollutants, pharmaceuticals, and occupational settings, pose significant risks to both acute and chronic neurological health. Conditions such as peripheral neuropathy, cognitive decline, and movement disorders can result from exposure to these toxins. Understanding the pathways through which neurotoxins exert their effects—such as through oxidative stress, inflammation, and mitochondrial dysfunction—has become a critical area of research. Additionally, advances in toxicology are leading to improved risk assessments, better safety protocols, and therapeutic interventions that can mitigate the damage caused by neurotoxic substances.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
Thomas J Webster
Interstellar Therapeutics, United States
Roger H Coletti
Interventional Health, PA, United States
Stephen Grossberg
Boston University, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States